Entrada Therapeutics, Inc.
Ticker: TRDA
Insider | Title |
---|---|
Andrew J. Schwab | 10% or greater ownership |
Ansbert Gadicke | 10% or greater ownership |
Asset Management Investors Bv2014 Llc Mpm | 10% or greater ownership |
Asset Management Investors Bv2018 Llc Mpm | 10% or greater ownership |
Bernhardt G Zeiher | Director |
Biopharma Investments Iii, L.p. Redmile | 10% or greater ownership |
Bioventures 2014 (b), L.p. Mpm | 10% or greater ownership |
Bioventures 2014 Gp Llc Mpm | 10% or greater ownership |
Bioventures 2014 Llc Mpm | 10% or greater ownership |
Bioventures 2014, L.p. Mpm | 10% or greater ownership |
Bioventures 2018 (b), L.p. Mpm | 10% or greater ownership |
Bioventures 2018 Gp Llc Mpm | 10% or greater ownership |
Bioventures 2018 Llc Mpm | 10% or greater ownership |
Bioventures 2018, L.p. Mpm | 10% or greater ownership |
Bros. Advisors (gp) Llc Baker | 10% or greater ownership |
Bros. Advisors Lp Baker | 10% or greater ownership |
Carole Nuechterlein | Director |
Dipal Doshi | CEO, Director |
Felix Baker | 10% or greater ownership |
Finance Ltd Roche | 10% or greater ownership |
Gina Chapman | Director |
Group, Llc Redmile | Director, 10% or greater ownership |
Holding Ltd Roche | 10% or greater ownership |
Jeremy Green | Director, 10% or greater ownership |
John F Crowley | Director |
Julian Baker | 10% or greater ownership |
Kory James Wentworth | Chief Financial Officer |
Kush Parmar | Director, 10% or greater ownership |
Luke Evnin | 10% or greater ownership |
Mary Thistle | Director |
Natarajan Sethuraman | President, Research Develop. |
Nathan J Dowden | President COO |
Nerissa Kreher | Chief Medical Officer |
Opportunities I (gp), Llc 5am | 10% or greater ownership |
Opportunities I, L.p. 5am | 10% or greater ownership |
Partners V, Llc 5am | 10% or greater ownership |
Peter S Kim | Director |
Scott M Rocklage | 10% or greater ownership |
Todd Foley | Director, 10% or greater ownership |
Ventures V, L.p. 5am | 10% or greater ownership |